LilrB3 is a putative cell surface receptor of APOE4

• Jiayao Zhou
• Yumeng Wang
• Yigong Shi

Article 02 January 2023

Featured

• 

  SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses

  • Shufen Li
  • Yulan Zhang
  • Ke Peng

  Article 17 Jan 2023
• 

  The compact Casπ (Cas12l) ‘bracelet’ provides a unique structural platform for DNA manipulation

  • Ao Sun
  • Cheng-Ping Li
  • Jun-Jie Gogo Liu

  Article 17 Jan 2023
• 

  Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria

  • Xiao-Qing Xie
  • Yi Yang
  • Xiu-Wu Bian

  Article Open Access 10 Jan 2023
• 

  Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1

  • Ping Luo
  • Wenbo Feng
  • Yi Jiang

  Article 02 Jan 2023

Current issue

• RASON, a new player in cancer’s Premier League

  • Sara Mainardi
  • Rene Bernards

  Research Highlight 02 Jan 2023

• Pituitary adenomas: new insights, new therapeutic targets

  • Nicholas A. Tritos

  Research Highlight 02 Jan 2023

• Towards developing a variant-proof SARS-CoV-2 vaccine

  • Hua Peng
  • Yang-Xin Fu

  Research Highlight 02 Jan 2023

• Unraveling female reproductive senescence to enhance healthy longevity

  • Lu Dong
  • Daniel Boon Loong Teh
  • Zhongwei Huang

  Review Article 02 Jan 2023

• A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

  • Rongjie Cheng
  • Fanying Li
  • Nu Zhang

  Article Open Access 14 Oct 2022

• Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1

  • Ping Luo
  • Wenbo Feng
  • Yi Jiang

  Article 02 Jan 2023

Contents

View all issues

Subscribe

• Center for Excellence in Molecular Cell Science

  

• SharedIt

  

• Guide to Authors

  

• Research Data

  

Advertisement

Browse articles

• 

  Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection

  • Bo Gao
  • Liheng He
  • Leng-Siew Yeap

  Letter to the Editor 25 Jan 2023

• Biochemical pathways of sleep

  • William Wisden
  • Nicholas P. Franks

  Research Highlight 24 Jan 2023
• 

  Mitochondrial PD-L1 modulates cancer immunotherapy

  • Xiaoming Dai
  • Jing Liu
  • Wenyi Wei

  Research Highlight 24 Jan 2023
• 

  Human endoderm stem cells reverse inflammation-related acute liver failure through cystatin SN-mediated inhibition of interferon signaling

  • Yilin Xu
  • Jinglin Wang
  • Xin Cheng

  Article Open Access 20 Jan 2023
• 

  SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses

  • Shufen Li
  • Yulan Zhang
  • Ke Peng

  Article 17 Jan 2023
• 

  The compact Casπ (Cas12l) ‘bracelet’ provides a unique structural platform for DNA manipulation

  • Ao Sun
  • Cheng-Ping Li
  • Jun-Jie Gogo Liu

  Article 17 Jan 2023
• 

  Dietary fibers & immunity—more than meets the eye

  • Yotam Cohen
  • Eran Elinav

  Research Highlight 16 Jan 2023
• 

  EMP1⁺ tumor cells drive metastatic relapse

  • Oscar E. Villarreal
  • Scott Kopetz

  Research Highlight 16 Jan 2023
• 

  Buckle up! How the nano-seatbelt MRAP1 fastens ACTH in its orthosteric seat

  • Daniel Hilger

  Research Highlight 16 Jan 2023

Collections

A special collection of reviews on frontiers in immunology

Chenqi Xu, Hua-Bing Li and Richard A. Flavell presented a special review collection in Cell Research discussing our understanding and perspectives of immunological frontiers. The review collection covered diverse topics including cancer immunology, immunometabolism, regulatory T cells, innate lymphoid cells, microbiota/immune interplay, and the inflammasome.

Focus 17 Sept 2020

Advertisement

Trending - Altmetric

• 

  Three-dimensional human facial morphologies as robust aging markers

• 

  Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells

• 

  Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection

• 

  LilrB3 is a putative cell surface receptor of APOE4

• 

  This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

•